Publication

Novel Ruthenium Complexes with Sterically Demanding Cyclopentadienyl Ligands

Related publications (74)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Novel Ruthenium Complexes with Sterically Demanding Cyclopentadienyl Ligands

Graph Chatbot

Chat with Graph Search

Modulating the Steric, Electronic, and Catalytic Properties of Cp* Ruthenium Half-Sandwich Complexes with β-Diketiminato Ligands

Antiproliferative activity of chelating N,O- and N,N-ruthenium(II) arene functionalised poly(propyleneimine) dendrimer scaffolds

Adding diversity to ruthenium(II)-arene anticancer (RAPTA) compounds via click chemistry: the influence of hydrophobic chains

Reactions of Alkynes with RuCl(Cyclopentadienyl) Complexes: The Important First Steps

Reactions of Alkynes with [RuCl(cyclopentadienyl)] Complexes: The Important First Steps

Functional Nanostructures Based on Organometallic Half-Sandwich Complexes

Development of Bimetallic Titanocene-Ruthenium-Arene Complexes As Anticancer Agents: Relationships between Structural and Biological Properties

Anticancer activity of new organo-ruthenium, rhodium and iridium complexes containing the 2-(pyridine-2-yl)thiazole N,N-chelating ligand

Metabolization of [Ru(η6-C6H5CF3)(pta)Cl2]: a cytotoxic RAPTA-type complex with a strongly electron withdrawing arene ligand

Rationalization of the inhibition activity of structurally related organometallic compounds against the drug target cathepsin B by DFT